IPSC 1.1 (+4.76%)
US15673T1007BiotechnologyBiotechnology

Century Therapeutics (IPSC) Stock Highlights

1.1 | +4.76%
2024-12-21 06:43:59
Century Therapeutics Inc is a biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with a significant unmet medical need. It is assembling a portfolio of allogeneic iNK and iT cell therapy product candidates across solid tumor and hematological malignancies.

Statistics

Range Today
1.04 1.12
Volume Today 1.02M
Range 1 Year
0.98 5.51
Volume 1 Year 78.25M
Range 3 Year
0.98 19.39
Volume 3 Year 141.78M
Range 10 Year
0.98 32.9
Volume 10 Year 166.64M

Highlights

Market Capitalization 122.44M (small)
Floating Shares 28.63M
Current Price 1.1
Price To Earnings -0.82
Price To Revenue -7.85
Price To Book 0.62
Earnings Per Share -1.82
Payout Ratio 0%

Performance

Latest +4.76%
1 Month -12.7%
3 Months -34.52%
6 Months -62.84%
1 Year -53.78%
3 Years -93.31%
5 Years -94.36%
10 Years -94.36%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.